Long-term opioid treatment and endocrine measures in patients with cancer-related pain: a systematic review

Keyphrases

• Patients with Cancer 100%
• Long-term Opioid 100%
• Opioid Treatment 100%
• Cancer Pain 100%
• Cortisol 33%
• Serum Concentration 33%
• Dose Level 33%
• Sexual Dysfunction 33%
• Free Testosterone 33%
• Total Testosterone 33%
• Opioid Dose 33%
• Endocrine System 33%
• Embase 16%
• Adult Patients 16%
• Inclusion Criteria 16%
• MEDLINE 16%
• Low Serum 16%
• Luteinizing Hormone 16%
• Follicle-stimulating Hormone 16%
• Sex Hormone Levels 16%
• Morphine Equivalent Dose 16%
• Hypofunction 16%
• Cancer Pain Management 16%
• Female Hormones 16%
• Opioid Analgesics 16%
• Concentration Level 16%
• Web of Science Database 16%
• ID number 16%
• Prospero 16%
• Systemic Review 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Opiate 100%
• Hydrocortisone 25%
• Testosterone 25%
• Cross-Sectional Study 12%
• Morphine 12%
• Clinical Study 12%
• Luteinizing Hormone 12%
• Sex Hormone 12%
• Cancer Pain 12%
• Narcotic Analgesic Agent 12%

Medicine and Dentistry

• Opiate 100%
• Hydrocortisone 25%
• Testosterone 25%
• Endocrine System 25%
• Sex Hormone 12%
• Clinical Study 12%
• Cross Sectional Study 12%
• Luteinizing Hormone 12%
• Morphine 12%
• Hormone Determination 12%
• Narcotic Analgesic Agent 12%
• Cancer Pain Management 12%